AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, M.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, M.D.

Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy

M.D. Hilla, A.M. Demchuka, T.A. Tomsickb, Y.Y. Paleschc, J.P. Broderickb on behalf of the IMS-1 Investigators

a From the Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
b the Cincinnati Stroke Program, Department of Neurology and Stroke, University of Cincinnati, Cincinnati, Ohio
c the Department of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC


Figure 1
View larger version (97K):

[in a new window]
 
Fig 1. A, Baseline CT scan at 100 minutes from stroke onset showing a left middle cerebral artery infarct with an ASPECT score of 8. Points are taken off for hypoattenuation of the head of caudate and the lentiform nuclei. Based upon our data, this patient would be an ideal candidate for IV-IA therapy.

B, Baseline CT scan at 175 minutes from stroke onset showing a well-evolved right middle cerebral artery infarct with an ASPECT score of 0. Based upon our data, this patient could be harmed by IV-IA therapy.


Figure 2
View larger version (20K):

[in a new window]
 
Fig 2. Modified Rankin Scale outcomes at 90 days stratified by the baseline ASPECT score and adjusted using ordered logistic regression for baseline age, NIH Stroke Scale score, onset-to-treatment time, and baseline serum glucose.